Gravicare 250mg Injection
Marketer
Santo Formulations
Salt Composition
Hydroxyprogesterone (250mg)
Overview Gravicare 250mg Injection
To curtail preterm labor and the associated risk of premature delivery in expectant mothers, the 250mg Gravicare injection is administered. This medication also helps mitigate miscarriage risk, particularly in women with a history of premature birth. Administration must be conducted by, or under the strict guidance of, a physician. Dosage and duration are determined solely by your doctor, and the prescribed regimen should be followed meticulously. Common side effects may include injection site reactions, nausea, pruritus, diarrhea, and skin rashes. Report any bothersome symptoms to your physician; management strategies may be available. Given its potential impact on blood glucose, regular monitoring is essential. Immediately report jaundice, dark urine, or abdominal distress to your doctor. Prior to commencing treatment, disclose any pre-existing conditions, such as circulatory problems, diabetes, or liver ailments. Furthermore, provide a complete list of all current medications, as interactions may compromise efficacy or alter the drug's action.
Primary Ingredients of Gravicare 250mg Injection
No text provided to rephrase.
Uses of Gravicare 250mg Injection
Avoiding Early Delivery
Major Benefits of Gravicare 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Gravicare 250mg Injection:
- Injection site pain
- Injection site swelling
- Red spots or bumps
- Rash
How to use Gravicare 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Gravicare 250mg Injection works:
Gravicare 250mg injection contains a progestin, a type of female hormone.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Gravicare 250mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Gravicare 250mg is typically deemed safe for use throughout gestation. Preclinical trials in animals revealed minimal or absent negative consequences for fetal development; clinical data from human trials, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation is compatible with the administration of Gravicare 250mg Injection. Research in human subjects indicates negligible transfer of the medication into breast milk, posing no appreciable risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Gravicare 250mg Injection.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gravicare 250mg Injection to individuals with impaired renal function. Physician consultation is advised. The drug's progesterone component may induce fluid retention in patients suffering from pre-existing kidney conditions.
LiverUNSAFE
Individuals with liver impairment should likely refrain from using Gravicare 250mg Injection due to potential safety concerns. Medical advice is recommended.
What if you forget to take Gravicare 250mg Injection :
Omitting a scheduled dose of Gravicare 250mg Injection necessitates contacting your physician.
Facts to Know About Gravicare 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Glucocorticoids, mineralocorticoids, and progestins |
| Developing Habits | No. |
| Treatment Category | OBSTETRICS AND GYNECOLOGY |
| Actions | First-Generation Progestins |
3,018 People bought this recently